Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-25

Clinical Trial Update: Study of Yupingfeng Powder Treating Allergic Rhinitis (AR) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating Yupingfeng Powder for allergic rhinitis, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yupingfeng Powder (Yu Ping Feng San)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Allergic Rhinitis | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING